🇺🇸 FDA
Patent

US 10285962

Glutarate compounds for treating ischemia-reperfusion injuries

granted A61KA61K31/194A61K31/198

Quick answer

US patent 10285962 (Glutarate compounds for treating ischemia-reperfusion injuries) held by The Regents of the University of California expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/194, A61K31/198, A61K31/365, A61K31/616